{"transactions":[{"id":1480462,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":11656,"kind":"person","name":"Mammen Mathai","position":1,"cik":"0001421050","reported_name":"Mammen Mathai","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2024-06-13T20:22:45.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":8649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2024, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":180259,"source":{"system":"sec-edgar","filing":"0001610717-24-000326","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421050/000161071724000326/form4.xml","form_type":"4"}},{"id":1851934,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":11656,"kind":"person","name":"Mammen Mathai","position":1,"cik":"0001421050","reported_name":"Mammen Mathai","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T21:40:00.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":4661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the total number of shares subject to the option vest on each monthly anniversary measured from June 14, 2023, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":4661,"derivative":{"exercise_price":57.62,"expiration_date":"2033-06-14","underlying":"Class A Common Stock","underlying_shares":4661},"source":{"system":"sec-edgar","filing":"0001610717-23-000173","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1421050/000161071723000173/form4.xml","form_type":"4"}},{"id":1851933,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":11656,"kind":"person","name":"Mammen Mathai","position":1,"cik":"0001421050","reported_name":"Mammen Mathai","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2023-06-16T21:40:00.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":1865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2023, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":171610,"source":{"system":"sec-edgar","filing":"0001610717-23-000173","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421050/000161071723000173/form4.xml","form_type":"4"}},{"id":1893379,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":11656,"kind":"person","name":"Mammen Mathai","position":1,"cik":"0001421050","reported_name":"Mammen Mathai","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-05-15T20:37:41.000Z","date":"2023-05-11","kind":"exercise","planned":false,"acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the shares subject to the option are fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":1.16,"expiration_date":"2027-06-12","underlying":"Class A Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001610717-23-000035","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1421050/000161071723000035/form4.xml","form_type":"4"}},{"id":1893378,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":11656,"kind":"person","name":"Mammen Mathai","position":1,"cik":"0001421050","reported_name":"Mammen Mathai","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2023-05-15T20:37:41.000Z","date":"2023-05-11","kind":"sale","planned":false,"acquired":false,"shares":33000,"price":52.8208,"value":1743086.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $52.43 to $53.26. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":169745,"source":{"system":"sec-edgar","filing":"0001610717-23-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1421050/000161071723000035/form4.xml","form_type":"4"}},{"id":1893377,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":11656,"kind":"person","name":"Mammen Mathai","position":1,"cik":"0001421050","reported_name":"Mammen Mathai","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2023-05-15T20:37:41.000Z","date":"2023-05-11","kind":"exercise","planned":false,"acquired":true,"shares":200000,"price":1.16,"value":232000.0,"ownership":{"direct":true},"balance_after":202745,"source":{"system":"sec-edgar","filing":"0001610717-23-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421050/000161071723000035/form4.xml","form_type":"4"}},{"id":2227490,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":11656,"kind":"person","name":"Mammen Mathai","position":1,"cik":"0001421050","reported_name":"Mammen Mathai","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T21:14:59.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one-twelfth of the shares on July 15, 2022 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":5300,"derivative":{"exercise_price":39.62,"expiration_date":"2031-06-15","underlying":"Class A Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001567619-22-013119","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1421050/000156761922013119/doc1.xml","form_type":"4"}},{"id":2227489,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":11656,"kind":"person","name":"Mammen Mathai","position":1,"cik":"0001421050","reported_name":"Mammen Mathai","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-06-17T21:14:59.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":2120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-fourth of the RSUs, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, shall vest on August 21, 2022 and on each three-month anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":2745,"source":{"system":"sec-edgar","filing":"0001567619-22-013119","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421050/000156761922013119/doc1.xml","form_type":"4"}},{"id":70415,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":11656,"kind":"person","name":"Mammen Mathai","position":1,"cik":"0001421050","reported_name":"Mammen Mathai","relationship":{"officer":true,"officer_title":"EVP, Pharm, R&D"}}],"security":"Performance Share Units","published_at":"2022-02-17T11:00:56.000Z","date":"2022-02-15","kind":"exercise","acquired":false,"shares":7740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited."}],"balance_after":737,"derivative":{"exercise_date":"2022-02-11","underlying":"Common Stock","underlying_shares":7740},"source":{"system":"sec-edgar","filing":"0001225208-22-002372","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520822002372/doc4.xml","form_type":"4"}},{"id":70414,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":11656,"kind":"person","name":"Mammen Mathai","position":1,"cik":"0001421050","reported_name":"Mammen Mathai","relationship":{"officer":true,"officer_title":"EVP, Pharm, R&D"}}],"security":"Restricted Share Units","published_at":"2022-02-17T11:00:56.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":3922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Awarded under Issuer's Long-Term Incentive Plan.  Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Awarded under Issuer's Long-Term Incentive Plan.  Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant."}],"balance_after":3922,"derivative":{"exercise_date":"2025-02-14","underlying":"Common Stock","underlying_shares":3922},"source":{"system":"sec-edgar","filing":"0001225208-22-002372","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520822002372/doc4.xml","form_type":"4"}},{"id":70413,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":11656,"kind":"person","name":"Mammen Mathai","position":1,"cik":"0001421050","reported_name":"Mammen Mathai","relationship":{"officer":true,"officer_title":"EVP, Pharm, R&D"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2022-02-17T11:00:56.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":38736,"price":165.89,"value":6425915.04,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Awarded under Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Awarded under Issuer's Long-Term Incentive Plan."}],"balance_after":38736,"derivative":{"exercise_date":"2025-02-14","expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":38736},"source":{"system":"sec-edgar","filing":"0001225208-22-002372","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520822002372/doc4.xml","form_type":"4"}},{"id":70412,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":11656,"kind":"person","name":"Mammen Mathai","position":1,"cik":"0001421050","reported_name":"Mammen Mathai","relationship":{"officer":true,"officer_title":"EVP, Pharm, R&D"}}],"security":"Common Stock","published_at":"2022-02-17T11:00:56.000Z","date":"2022-02-15","kind":"tax_withholding","acquired":false,"shares":3366,"price":165.89,"value":558385.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of Performance Share Units."}],"balance_after":41934,"source":{"system":"sec-edgar","filing":"0001225208-22-002372","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520822002372/doc4.xml","form_type":"4"}},{"id":70411,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":11656,"kind":"person","name":"Mammen Mathai","position":1,"cik":"0001421050","reported_name":"Mammen Mathai","relationship":{"officer":true,"officer_title":"EVP, Pharm, R&D"}}],"security":"Common Stock","published_at":"2022-02-17T11:00:56.000Z","date":"2022-02-15","kind":"exercise","acquired":true,"shares":7740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting."}],"balance_after":45300,"source":{"system":"sec-edgar","filing":"0001225208-22-002372","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520822002372/doc4.xml","form_type":"4"}},{"id":70837,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":11656,"kind":"person","name":"Mammen Mathai","position":1,"cik":"0001421050","reported_name":"Mammen Mathai","relationship":{"officer":true,"officer_title":"EVP, Pharm, R&D"}}],"security":"Restricted Share Units","published_at":"2022-02-16T01:03:54.000Z","date":"2022-02-14","kind":"exercise","acquired":false,"shares":7418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting."}],"balance_after":0,"derivative":{"exercise_date":"2022-02-11","underlying":"Common Stock","underlying_shares":7418},"source":{"system":"sec-edgar","filing":"0001225208-22-002220","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520822002220/doc4.xml","form_type":"4"}},{"id":70836,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":11656,"kind":"person","name":"Mammen Mathai","position":1,"cik":"0001421050","reported_name":"Mammen Mathai","relationship":{"officer":true,"officer_title":"EVP, Pharm, R&D"}}],"security":"Common Stock","published_at":"2022-02-16T01:03:54.000Z","date":"2022-02-14","kind":"tax_withholding","acquired":false,"shares":2335,"price":168.85,"value":394264.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of Restricted Share Units."}],"balance_after":37560,"source":{"system":"sec-edgar","filing":"0001225208-22-002220","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520822002220/doc4.xml","form_type":"4"}},{"id":70835,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":11656,"kind":"person","name":"Mammen Mathai","position":1,"cik":"0001421050","reported_name":"Mammen Mathai","relationship":{"officer":true,"officer_title":"EVP, Pharm, R&D"}}],"security":"Common Stock","published_at":"2022-02-16T01:03:54.000Z","date":"2022-02-14","kind":"exercise","acquired":true,"shares":7418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting."}],"balance_after":39895,"source":{"system":"sec-edgar","filing":"0001225208-22-002220","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000122520822002220/doc4.xml","form_type":"4"}},{"id":2668141,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":11656,"kind":"person","name":"Mammen Mathai","position":1,"cik":"0001421050","reported_name":"Mammen Mathai","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-15T21:50:53.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":1563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one-twelfth of the shares on July 11, 2021 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":1563,"derivative":{"exercise_price":193.51,"expiration_date":"2031-06-11","underlying":"Class A Common Stock","underlying_shares":1563},"source":{"system":"sec-edgar","filing":"0001209191-21-040689","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1421050/000120919121040689/doc4.xml","form_type":"4"}},{"id":2668140,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":11656,"kind":"person","name":"Mammen Mathai","position":1,"cik":"0001421050","reported_name":"Mammen Mathai","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-15T21:50:53.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-fourth of the RSUs, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, shall vest on August 21, 2021 and on each three-month anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":625,"source":{"system":"sec-edgar","filing":"0001209191-21-040689","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421050/000120919121040689/doc4.xml","form_type":"4"}},{"id":3106881,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":11656,"kind":"person","name":"Mammen Mathai","position":1,"cik":"0001421050","reported_name":"Mammen Mathai","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-17T20:29:17.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":4432,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one-twelfth of the shares on July 15, 2020 and each month thereafter, subject to the reporting person continuing as a service provider through each such date."}],"balance_after":4432,"derivative":{"exercise_price":88.42,"expiration_date":"2030-06-15","underlying":"Class A Common Stock","underlying_shares":4432},"source":{"system":"sec-edgar","filing":"0001209191-20-037270","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421050/000120919120037270/doc4.xml","form_type":"4"}},{"id":3413835,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":11656,"kind":"person","name":"Mammen Mathai","position":1,"cik":"0001421050","reported_name":"Mammen Mathai","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-09-16T20:19:01.000Z","date":"2019-09-16","kind":"other","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Class B Common Stock was reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth of the shares subject to the option vested on July 12, 2017 and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. This option may be exercised prior to vesting, subject to the Issuer's right to repurchase unvested shares."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Class B Common Stock was reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering."}],"balance_after":200000,"derivative":{"exercise_price":1.16,"expiration_date":"2027-06-12","underlying":"Class A Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-19-023636","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1421050/000089924319023636/doc4.xml","form_type":"4"}},{"id":3413834,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":11656,"kind":"person","name":"Mammen Mathai","position":1,"cik":"0001421050","reported_name":"Mammen Mathai","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-09-16T20:19:01.000Z","date":"2019-09-16","kind":"other","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Class B Common Stock was reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth of the shares subject to the option vested on July 12, 2017 and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. This option may be exercised prior to vesting, subject to the Issuer's right to repurchase unvested shares."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Class B Common Stock was reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"exercise_price":1.16,"expiration_date":"2027-06-12","underlying":"Class B Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-19-023636","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421050/000089924319023636/doc4.xml","form_type":"4"}}]}